These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26680515)

  • 21. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
    Sun Z; Gong Y; Huang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
    Gandolfo S; Castellani R; Pentenero M
    J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
    Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
    Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative verrucous leukoplakia: a case report.
    Lopes MA; Pazoki AE; Ord RA
    Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.
    Brouns E; Baart J; Karagozoglu Kh; Aartman I; Bloemena E; van der Waal I
    Oral Dis; 2014 Apr; 20(3):e19-24. PubMed ID: 23521625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes of oral leukoplakia on the irradiated or nonirradiated mucosa among survivors of head and neck cancer in the papulation where practice of betel nut chewing and cigarette smoking are widespread.
    Yang SW; Lin CY; Lee YS; Huang SM
    BMC Oral Health; 2024 Jul; 24(1):851. PubMed ID: 39061032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
    Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
    J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases.
    Liu W; Shen XM; Liu Y; Li J; Zhou ZT; Wang LZ
    J Oral Pathol Med; 2011 Apr; 40(4):312-6. PubMed ID: 21342275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan.
    Shiu MN; Chen TH; Chang SH; Hahn LJ
    Br J Cancer; 2000 Jun; 82(11):1871-4. PubMed ID: 10839305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of MAGE-A expression predicts malignant transformation of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Gorecki P; Neukam FW; Strassburg LH; Nkenke E
    Cancer Invest; 2012 Aug; 30(7):495-502. PubMed ID: 22646284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathological Study of the Resected Oral Leukoplakia Cases].
    Koike T; Kanno T; Karino M; Tatsumi H; Tsunematsu K; Odawara S; Nariai Y; Hideshima K; Sekine J
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1970-1972. PubMed ID: 30692414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G; De Luca F; Lanza A; Tartaro GP
    Minerva Stomatol; 1995 Jun; 44(6):291-300. PubMed ID: 7476784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Leukoplakia of the oral cavity].
    Petit JC
    Rev Belge Med Dent (1984); 1989; 44(4):59-77. PubMed ID: 2699668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
    Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.
    Staines K; Rogers H
    Br Dent J; 2017 Dec; 223(9):655-661. PubMed ID: 29097794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intervention efficacy and malignant transformation to oral cancer among patients with leukoplakia (Review).
    Shiu MN; Chen TH
    Oncol Rep; 2003; 10(6):1683-92. PubMed ID: 14534680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients.
    Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
    J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.